High stromal transforming growth factor β-induced expression is a novel marker of progression and poor prognosis in gastric cancer.

Masaki Suzuki Takehiko YokoboriNavchaa GombodorjMasakazu YashiroAndrei TurtoiTadashi HandaKyoichi OgataTetsunari OyamaKen ShirabeHiroyuki Kuwano

Published in: Journal of surgical oncology (2018)

High stromal TGFBI expression might be a useful predictive marker for poor prognosis in GC patients. Furthermore, TGFBI in the cancer stromal cells is a promising target for GC treatment.

Keyphrases

poor prognosis
long non coding rna
transforming growth factor
bone marrow
epithelial mesenchymal transition
end stage renal disease
newly diagnosed
ejection fraction
prognostic factors
papillary thyroid
squamous cell carcinoma
signaling pathway
drug induced
combination therapy
simultaneous determination